Concepedia

Fedor N. Novikov

FN

Statistics

Publications

24

Citations

784

H-Index

15

Active since

2008

Affiliations

N.D. Zelinsky Institute of Organic Chemistry(Current)

Lomonosov Moscow State University

A. N. Nesmeyanov Institute of Organoelement Compounds

National Research University Higher School of Economics

National Medical Research Center for Hematology

Fedor N. Novikov is an author at N.D. Zelinsky Institute of Organic Chemistry specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

2008–2023

24

Publications

24

Lead Finder: An Approach To Improve Accuracy of Protein−Ligand Docking, Binding Energy Estimation, and Virtual Screening

Oleg V. Stroganov, Fedor N. Novikov, Viktor S. Stroylov et al. · Journal of Chemical Information and Modeling · 2008 · 223 citations

, , +17

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation

Afsar Mian, Alireza Rafiei, Isabella Haberbosch et al. · Leukemia · 2014 · 65 citations

, , +6

Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin

Marina Sagnou, Fedor N. Novikov, Ekaterina S. Ivanova et al. · European Journal of Medicinal Chemistry · 2020 · 50 citations

, , +11

Quantifying Possible Routes for SpnF-Catalyzed Formal Diels–Alder Cycloaddition

Michael G. Medvedev, Alexey A. Zeifman, Fedor N. Novikov et al. · Journal of the American Chemical Society · 2017 · 44 citations

, , +15

Lead Finder docking and virtual screening evaluation with Astex and DUD test sets

Fedor N. Novikov, Viktor S. Stroylov, Alexey A. Zeifman et al. · Journal of Computer-Aided Molecular Design · 2012 · 42 citations

, , +16

1–5 of 24